Related Experiment Video
Updated: Jan 13, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Echocardiographic hemodynamics correlate with differences in DOAC-specific bleeding and stroke rates in non-valvular
Michael P O'Shea1,2,3, Ali Yusuf4, Eiad Habib4
1Mayo Clinic, 134000 E Shea Blvd, Scottsdale, AZ, 85259, USA. osheam12@tcd.ie.
Insights
Direct oral anticoagulants (DOACs) reduce stroke risk in non-valvular atrial fibrillation. Elevated right ventricular systolic pressure (RVSP) increases bleeding risk with dabigatran and rivaroxaban, but not apixaban.
Area of Science:
- Cardiology
- Pharmacology
- Medical Imaging
Background:
- Direct oral anticoagulants (DOACs) are standard for stroke prevention in non-valvular atrial fibrillation/flutter (NVAF).
- Different DOACs exhibit varying bleeding profiles, with apixaban noted for the lowest risk.
- Right ventricular systolic pressure (RVSP) is an echocardiographic measure that may influence bleeding risk.
Purpose of the Study:
- To investigate the interaction between DOAC selection and RVSP on echocardiogram concerning bleeding rates.
- To test the hypothesis that elevated RVSP is linked to increased bleeding, potentially modulated by DOAC pharmacologic properties.
Main Methods:
- Retrospective analysis of a clinical database involving patients who underwent echocardiography.
- Multivariable regression models were employed to assess bleeding rates, adjusting for confounders.
- Interaction terms for DOAC choice and RVSP status were incorporated into the models.
Main Results:
- Apixaban was associated with lower bleeding rates compared to rivaroxaban and dabigatran overall.
- No significant difference in bleeding rates was observed between DOACs in patients without elevated RVSP.
- In patients with RVSP ≥45mmHg, dabigatran and rivaroxaban showed significantly increased bleeding rates (90% and 86% increase, respectively) compared to apixaban.
Conclusions:
- Elevated RVSP is a significant risk factor for excess bleeding in patients on certain DOACs.
- The increased bleeding risk associated with elevated RVSP was observed with dabigatran and rivaroxaban, but not apixaban.
- These findings highlight the importance of considering RVSP in conjunction with DOAC choice for personalized bleeding risk assessment in NVAF patients.
Aims:
Direct oral anticoagulants (DOACs) are widely used for stroke prevention in people with non-valvular atrial fibrillation/flutter (NVAF).Anticoagulants have different bleeding profiles. Apixaban is associated with the lowest bleeding risk. This study evaluates the interaction between DOAC use and right ventricular systolic pressure (RVSP) on echocardiogram and bleeding rates. It was hypothesized that elevated RVSP may be associated with excess bleeding based on anticoagulant-specific pharmacologic profiles.
Methods& Results:
A retrospective analysis of a database was conducted. Multivariable regression models for bleeding rates were developed using an analysis approach that adjusts for confounders among participants who had undergone an echocardiogram, and interaction terms for DOAC choice were incorporated. Stratum-specific estimates were calculated using linear computation. Patients taking apixaban had lower bleeding rates than those taking rivaroxaban and dabigatran. Among those without elevated RVSP, there was no difference in bleeding rates. Where RVSP was ≥45mmHg, there was a 90% increase in bleeding rates with use of dabigatran (HR 1.99, p=0.024) and rivaroxaban (HR 1.86, p=0.042) compared to apixaban (Table 1D).
Conclusions:
Elevated RVSP is associated with excess bleeding in patients taking rivaroxaban and dabigatran, but not apixaban, after controlling for confounding variables.
More Related Videos
08:12Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies